Shawn Rose
Förmögenhet: - $ per 2026-08-31
Förmögenhet: - $ per 2026-08-31
Dr. Shawn Rose is a Chief Medical Officer, Head-Research & Development at Nkarta, Inc. Dr. Rose was previously employed as a Senior Vice President & Head-Clinical Development by Magenta Therapeutics, Inc. and a Chief Development Officer-Immunology by Vividion Therapeutics, Inc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NKARTA, INC. -.--% | 2026-04-17 | 0 ( -.--% ) | - $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| NKARTA, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-23 |
| Företag | Position | Slut |
|---|---|---|
| MAGENTA THERAPEUTICS | Teknisk/Vetenskaplig/F&U Direktör | 2023-02-07 |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Nkarta, Inc.
Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån